Symptomatic intracranial hemorrhage after intravenous thrombolysis in ischemic stroke:prediction and treatment
10.3760/cma.j.issn.1673-4165.2018.03.008
- VernacularTitle:缺血性卒中静脉溶栓后有症状颅内出血:预测和治疗
- Author:
Shaowan YANG
1
;
Zhigang LIANG
;
Guoping YU
Author Information
1. 264000,青岛大学附属烟台毓璜顶医院神经内科
- Keywords:
Stroke;
Brain Ischemia;
Thrombolytic Therapy;
Cerebral Hemorrhage;
Intracranial Hemorrhages;
Tissue Plasminogen Activator;
Administration,Intravenous;
Risk Assessment
- From:
International Journal of Cerebrovascular Diseases
2018;26(3):201-206
- CountryChina
- Language:Chinese
-
Abstract:
[Abstraet] Alteplase intravenous thrombolysis is the most effective drug treatment for acute ischemic stroke at present.Hemorrhagic transformation after thrombolysis,especially symptomatic intracranial hemorrhage (sICH),will seriously affect the outcomes after intravenous thrombolysis,and even threaten the life of patients.Therefore,the prediction and treatment of sICH after intravenous thrombolysis is particularly important.This article reviews the prediction and treatment of sICH after intravenous thrombolysis.
